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	 Are	serum	uric	acid	levels		
always	elevated	in	acute	gout?
 no.	Many	patients	with	acute	gout
	 (11%-49%)	 have	 normal	 serum	
uric	acid	(SUA)	 levels (strength	of	recom-
mendation	 [SOR]:	 A,	 prospective	 cohort	
studies).	 Patients	 taking	 allopurinol	 are	
significantly	 more	 likely	 to	 have	 normal	
uric	 acid	 levels	 during	 acute	 gout	 attacks	
(SOR:	 B,	 extrapolated	 from	 prospective	
cohorts).
Evidence summary
Six	studies	have	evaluated	SUA	levels	in	pa-
tients	 with	 acute	 gout.	 Despite	 variations	
in	 diagnostic	 approach	 (clinical	 criteria	 vs	
synovial	 crystal	 analysis)	 and	 definitions	 of	
normal	 SUA	 (based	 on	 laboratory	methods	
and	 sex),	 all	 6	 studies	 found	 normal	 levels	
in	 11%	 to	 49%	 of	 patients	 with	 acute	 gout	
(TABLE 1).
Elevated SUA can be an indicator 
of gout—or not
A	prospective	cohort	study	of	82	patients	at	a	
Veterans	Administration	rheumatology	clinic	
found	elevated	SUA	to	be	the	most	sensitive	
indicator	 among	 various	 clinical	 criteria	 for	
diagnosing	 acute	 gout.	However,	 3	 (11%)	 of	
the	28	patients	who	had	crystal-proven	gout	
also	had	a	normal	SUA.1	
A	second	prospective	cohort	study	that	
evaluated	 38	 patients	 during	 42	 episodes	
of	 acute	 gout	 in	 various	 clinical	 settings	
reported	 a	 normal	 SUA	 in	 43%	 of	 patients	
diagnosed	on	clinical	grounds	or	by	joint	as-
piration.2
Some patients become hyperuricemic  
after diagnosis
The	largest	retrospective	cohort	study	evalu-
ated	 226	 Korean	 inpatients	 with	 acute	 gout	
diagnosed	 either	 by	 synovial	 crystals	 or	
American	 College	 of	 Rheumatology	 (ACR)	
criteria	(TABLE 2).	It	found	that	12%	(27)	had	
a	 normal	 SUA	 at	 diagnosis.	 Interestingly,	
81%	became	hyperuricemic	some	time	after	
diagnosis.3
What is a normal SUA value?
Another	 study	 reviewed	 SUA	 levels	 in	 a	 co-
hort	derived	from	2	large	prospective	RCTs	of	
etoricoxib	 in	 patients	 diagnosed	 with	 acute	
gout	 by	 crystal	 analysis.	 The	 proportion	 of	
patients	with	a	normal	 SUA	varied	 substan-
tially	 according	 to	 the	 definition	 of	 a	 nor-
mal	value:	32%	were	normal	using	a	value	of	
0.48	 mmol/L;	 11%	 had	 normal	 SUA	 levels	
when	0.36	mmol/L	was	used	as	the	cutoff.4
A	secondary	analysis	evaluated	the	effect	
of	allopurinol	on	SUA.	The	proportion	of	pa-
tients	on	allopurinol	with	a	normal	SUA	level	
compared	with	patients	not	 taking	allopuri-
nol	was	49%	vs	29%	using	the	higher	normal	
cutoff	value,	and	29%	vs	11%	using	the	lower	
normal	value	(P<.001).4
Two studies find many gout patients  
with a normal SUA
A	 Japanese	 retrospective	 cohort	 study	using	
ACR	criteria	found	that	nearly	half	of	patients	
diagnosed	with	acute	gout	had	a	normal	SUA	
level.5	 A	 1967	 retrospective	 examination	 of	
Framingham	 Heart	 Study	 data	 found	 that	
one-third	 of	 patients	 clinically	 diagnosed	
with	gout	had	a	normal	level.	Some	of	the	pa-
tients	hadn’t	been	diagnosed	at	the	time	their	
SUA	was	measured,	however.6	
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The proportion 
of patients 
with normal 
serum uric acid 
levels varies 
substantially, 
depending on 
how a normal 
value is defined.
Recommendations
The	 ACR’s	 1977	 criteria	 for	 diagnosing	 gout	
include	hyperuricemia	as	one	potential	indi-
cator.7	The	 European	 League	 Against	 Rheu-
matism	advises	 that	normal	 SUA	 levels	may	
accompany	crystal-proven	gout	because	uric	
TABLE 1 
Serum	uric	acid	and	acute	gout:	The	evidence
 
Type of cohort (n)
 
loE*
 
Setting
method  
of diagnosis
% with normal 
serum uric acid
Prospective1 (28) 1b Veterans 
administration 
rheumatology clinic
crystal positivity 11%
Prospective2 (38) 1b multiple settings (eg, 
inpatient, clinic, ED)
clinical criteria 
or crystal 
positivity
43%
retrospective3 (226) 2b hospitalized patients clinical criteria 
or crystal 
positivity
12%
retrospective4 (339) 2b multiple settings crystal positivity 32%
retrospective5 (41) 2b rheumatology clinic clinical criteria 49%
retrospective6 (69) 2b multiple settings clinical criteria 33%†
ED, emergency department; loE, level of evidence.
*1b, prospective cohort study with good follow-up (>80%); 2b, retrospective cohort study or prospective study with poor 
follow-up. 
†Not necessarily during acute gout.
TABLE 2 
American	College	of	Rheumatology	criteria		
for	classifying	acute	gouty	arthritis
•	 characteristic urate crystals in the joint fluid (or)
•	 a tophus proved to contain urate crystals by chemical means or polarized light microscopy (or)
•	 Six of the following 12 clinical, laboratory, and radiographic phenomena:
	 –	 more than one attack of acute arthritis
	 –	 maximal inflammation developing within one day
	 –	 attack of monoarticular arthritis
	 –	 Joint redness 
	 –	 First metatarsophalangeal joint is painful or swollen
	 –	 unilateral attack involving first metatarsophalangeal joint
	 –	 unilateral attack involving tarsal joint
	 –	 Suspected tophus
	 –	 hyperuricemia
	 –	 asymmetric swelling within a joint (radiograph)
	 –	 Subcortical cysts without erosions (radiograph)
	 –	 Negative culture of joint fluid for microorganisms during attack of joint inflammation
Source: Wallace Sl et al. Arthritis Rheum. 1977.7
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